Compounded semaglutide: cost, evidence, and the honest comparison
The active molecule is the same semaglutide found in approved products, but the finished preparation, its concentration, and any added ingredients are made by a compounding pharmacy rather than a manufacturer under FDA review.
What it's approved for#
Not an FDA-approved product. Compounded medications are prepared by licensed pharmacies for an individual patient under a prescription; the formulation itself is not FDA-reviewed for safety, effectiveness, or manufacturing quality.
What the research actually shows#
There are no trials of compounded formulations themselves. Efficacy claims borrow from studies of the FDA-approved products, which is a real limitation to weigh — as is the fact that Stanford clinicians and the FDA have both flagged additive and dosing-error concerns in this market.
Sources: FDA: concerns with unapproved GLP-1 drugs · Stanford Medicine on compounded GLP-1 safety, July 2026
Side effects, stated plainly#
The class effects apply, plus risks specific to compounding: unreviewed formulations, salt-form substitutions the FDA has warned about, and self-drawn dosing from vials. Verify the pharmacy before you verify the price.
What it costs#
This is the value end of the market — roughly $139 to $297 a month all-in — but the price gap versus brand direct has narrowed sharply since manufacturers cut cash prices. For many buyers at starter doses, brand is now cheaper.
| Channel | Form & dose | Med | Required fee | True monthly | Status |
|---|---|---|---|---|---|
| CoraLOWEST LISTED | injection · flat, annual prepay ($1,188) | $99 | — | $99 | listed |
| Trimi | injection · flat, annual plan only | $99 | — | $99 | listed |
| Mochi Health | injection · starter dose | $60 | $79/mo | $139 | listed |
| Shed (ShedRx) | injection · annual plan | $159 | — | $159 | listed |
| Found | injection · cash, 12-month plan paid up front | $169 | — | $169 | listed |
| Cora | injection · flat, monthly billing | $175 | — | $175 | listed |
| Mochi Health | injection · top dose | $99 | $79/mo | $178 | listed |
| Noom Med | injection · microdose, all-in | $179 | — | $179 | listed |
| Henry Meds | injection · from $179 | $179 | — | $179 | listed |
| Direct Meds | sublingual drops · flat rate | $179 | — | $179 | listed |
| Shed (ShedRx) | injection · monthly billing | $199 | — | $199 | listed |
| Noom Med | injection · full dose, all-in | $279 | — | $279 | listed |
| Found | injection · cash, month-to-month | $289 | — | $289 | listed |
| Direct Meds | injection · all-inclusive, month-to-month | $297 | — | $297 | listed |
True monthly = medication plus any required membership fee. Cheapest listed right now: Cora at $99/month. Full table and filters on the Compounded semaglutide cost page.
Coupon or manufacturer program?#
Compounded preparations are not FDA-approved products, so manufacturer programmes do not cover them and discount cards do not apply. What you pay is whatever the provider charges, which is why the all-in comparison matters more here than anywhere else on the site.
Watch for required membership fees quoted separately from the medication — the total is what leaves your account.
The full reasoning, including why "as low as" banners usually quote someone else's discount, is in the coupon analysis.
Keep reading#
Common questions#
Is compounded semaglutide legal right now?#
Patient-specific 503A compounding under a prescription remains legal when it meets the conditions — a documented clinical need for something the approved product does not offer, and not being 'essentially a copy'. Bulk 503B compounding is what the FDA moved to end. Our explainer walks the distinction.
How do I check a compounding pharmacy is real?#
Get the pharmacy's name before paying, look it up on its state board of pharmacy and on safe.pharmacy, and verify any LegitScript or PCAB seal on the certifier's own site rather than the seller's page.
Other weight loss medications#
Wegovy · Zepbound · Foundayo · Ozempic · Compounded tirzepatide · Liraglutide · Mounjaro
Compounded semaglutide market news#
The complaint targets sharing sensitive health data with ad platforms and ROSCA billing/cancellation practices — context for anyone weighing the $149/month membership model.
The Hims dossier →Participating Part D plans now cover Wegovy (pen and pill), Foundayo, and the Zepbound KwikPen at a flat $50 monthly copay through 2027 — below every cash price we track.
How the Bridge actually works →The proposed 503B Bulks List exclusion would close the mass-compounding era for good. Patient-specific 503A compounding continues — the legal market our index tracks at $139–$297 all-in.
The surviving market, explained →All tracked news → · Subscribe to this beat (RSS) · Fed by a daily automated scan; entries publish only after primary-source verification.
Educational and pricing journalism, not medical advice — indications, dosing, and suitability are decisions for you and a licensed clinician, and the FDA label is the authority on risks. Prices carry the verification dates shown; the provider's checkout is the final word. No link on this page earns us a commission; rankings are ordered by cost, never compensation — disclosure.